The oral administration of large amounts of ethinyl estradial ldaily to patients with coronary arteriosclerosis and to control subjects consistently prodluced a favorable effect upon the serum lipid pattern. However 
in the serum phospholipid content. Glass and coworkers4 in a study of 16 men and 15 women in the age group 55 to 65 years found no evidence that estradiol in doses of 0.25 to 0.75 mg. daily for periods of from two to four months influenced the level of either the serum lipids or the low density lipoproteins. Barr,5 however, reported that the administration of 1 mg. per day of ethinyl estradiol or an equivalent amount of Premarin* to survivors of myocardial infarction was followed by decreases in the serum cholesterol level and increases in serum phospholipid levels. As a result the cholesterolphospholipid ratio dropped from a mean value of 1.05 to 0.72. This change was shown to be due largely to 
